Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

The present invention relates to processes for preparing solid state forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, including Compound 1 Form A, Compound 1 Form A-HCl, Compound 1 Form B, and Compound 1 Form B-HC...

Full description

Saved in:
Bibliographic Details
Main Authors NUMA MEHDI, AMBHAIKAR NARENDRA BHALCHANDRA, ROEPER STEFANIE, SHETH URVI, HURLEY DENNIS JAMES, HUGHES ROBERT, LEE ELAINE CHUNGMIN, LITTLER BENJAMIN
Format Patent
LanguageEnglish
Published 17.06.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to processes for preparing solid state forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, including Compound 1 Form A, Compound 1 Form A-HCl, Compound 1 Form B, and Compound 1 Form B-HCl, any combination of these forms, pharmaceutical compositions thereof, and methods of treatment therewith.
Bibliography:Application Number: US201213678840